or Try an Advanced Search...

    Technical Analysis for ACIU - AC Immune SA

    Grade Last Price % Change Price Change
    D 3.24 0.00% 0.00
    ACIU closed down 0.92 percent on Wednesday, November 20, 2024, on 53 percent of normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical ACIU trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    50 DMA Resistance Bearish -0.92%
    MACD Bullish Centerline Cross Bullish -0.92%
    50 DMA Resistance Bearish 3.35%
    Calm After Storm Range Contraction 3.35%
    Fell Below 200 DMA Bearish 1.57%
    Fell Below 50 DMA Bearish 1.57%
    Upper Bollinger Band Touch Strength 1.57%
    Older End-of-Day Signals for ACIU ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    Fell Below 10 DMA about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ACIU Chart by TradingView
    Basic chart:

    Profile

    AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Dementia Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline

    Is ACIU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
    Nov 15 AC Immune reports interim results from Phase 2 trial of ACI-7104.056
    Nov 14 AC Immune stock jumps 20% on data for Parkinson's disease drug
    Nov 14 AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    Nov 13 AC Immune to Present at the Jefferies 2024 London Healthcare Conference
    Nov 9 AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates
    Nov 5 AC Immune: Q3 Earnings Snapshot
    Nov 5 AC Immune GAAP EPS of CHF0.05, revenue of CHF25.4M
    Nov 5 AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
    Oct 28 AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%
    See more ACIU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.14
    52 Week Low 2.25
    Average Volume 111,267
    200-Day Moving Average 3.35
    50-Day Moving Average 3.29
    20-Day Moving Average 3.12
    10-Day Moving Average 3.22
    Average True Range 0.23
    RSI (14) 51.69
    ADX 20.34
    +DI 27.49
    -DI 12.88
    Chandelier Exit (Long, 3 ATRs) 3.19
    Chandelier Exit (Short, 3 ATRs) 3.49
    Upper Bollinger Bands 3.42
    Lower Bollinger Band 2.81
    Percent B (%b) 0.7
    BandWidth 19.68
    MACD Line 0.01
    MACD Signal Line -0.02
    MACD Histogram 0.0268
    Fundamentals Value
    Market Cap 320.12 Million
    Num Shares 98.8 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -3.45
    Price-to-Sales 284765.75
    Price-to-Book 1.86
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.53
    Resistance 3 (R3) 3.55 3.48 3.48
    Resistance 2 (R2) 3.48 3.41 3.47 3.46
    Resistance 1 (R1) 3.36 3.36 3.33 3.34 3.45
    Pivot Point 3.29 3.29 3.27 3.28 3.29
    Support 1 (S1) 3.17 3.22 3.14 3.15 3.03
    Support 2 (S2) 3.10 3.17 3.09 3.02
    Support 3 (S3) 2.98 3.10 3.00
    Support 4 (S4) 2.96